Prodrug esters of the indolocarbazole CEP-751 (KT-6587)

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 14, 1998, Pages 1873-1876

  Hudkins, Robert L ^a   Iqbal, Mohamed ^a   Park, Chung Ho ^a   Goldstein, Joel ^c   Herman, Joseph L ^c   Shek, Efraim ^c   Murakata, Chikara ^b   Mallamo, John P ^a  

^a CEPHALON INC   (United States)

^b KYOWA HAKKO KOGYO CO LTD   (Japan)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEP 2563; CEP 751; INDOLE DERIVATIVE; KT 8391; PRODRUG; UNCLASSIFIED DRUG;

ARTICLE; DERIVATIZATION; DRUG HYDROLYSIS; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS;

ANIMALS; ANTINEOPLASTIC AGENTS; CARBAZOLES; DRUG SCREENING ASSAYS, ANTITUMOR; ESTERS; HUMANS; PRODRUGS;

EID: 0032555191     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00328-X     Document Type: Article

References (8)

1. 1. Bundgaard, H. In Design of Prodrugs; Bundgaard, H., Ed.; Eisevier: Amsterdam, 1985, Chapter 1.
2. 2. Kase, H.; Iwahashi, K.; Nakanishi, S.; Matsuda, Y.; Yamada, K.; Takahashi, M.; Murakata, C.; Sato, A.; Kaneko, M. Biochem. Biophys. Res. Commun. 1987, 142, 436.
3. 3. (a) Berg, M. M.; Sternberg, D. W.; Parada, L. F.; Chao, M. V. J. Biol. Chem. 1992, 267, 13.
4. (b) Tapley, P.; Lamballe, F.; Barbacid, M. Oncogene 1992, 7, 371.
5. (c) Ohmichi, M.; Decker, S. J.; Pang, L.; Saltiel, A. R. Biochemistry 1992, 31, 4034.
6. 4. Djakiew, D.; Delsite, R.; Pflug, B.; Wrathall, J.; Lynch, J. H.; Onoda, M. Cancer Res. 1991, 51, 3304.
7. 5. Camoratto, A. M.; Jani, J. P.; Angeles, T. S.; Maroney, A. C.; Sanders, C. Y.; Murakata, C.; Neff, N. T.; Vaught, J. L.; Isaacs, J. T.; Dionne, C. A. Int. J. Cancer 1997, 72, 673.
8. 6. Anderson, B. D.; Conradi, R. A.; Knuth, K. E. J. Pharma. Sci. 1985, 74, 365.